Sentences with phrase «drug companies in»

Customers able to afford medicine they may not otherwise be able to; drug companies in turn widen their customer base; and pharmacies get people in the door to sell non-medication products and services.

We have represented clients in numerous other congressional investigations and oversight hearings, including a major internet services company in an investigation of its practices abroad, a chemical manufacturer in an investigation of the safety of its products, an insurance company in a hearing on the federal long term care insurance program, a financial services company in an investigation of credit card terms, and drug companies in investigations concerning such matters as payments to doctors, marketing practices, generic approvals, drug importation, and drug safety.

We are not afraid to after even the largest drug companies in the world.

After for more than 130 years in business, C.B. Fleet Company is one of the largest non-prescription drug companies in the United States.

Not only has the information we have been given about fitness been untrue, most of it has been fabricated by greedy processed food manufacturers and drug companies in order to keep up us sick, sad, stupid and FAT.

According to Ackman, Valeant has spent $ 40 billion acquiring drugs or drug companies in the past five years or so.

But today, his fund, which once grew as large as $ 36 billion under management in 2011, has dwindled to $ 10 billion, following double - digit losses on wrong - footed bets on drug companies in 2016.

They're looking at the same types of pharmacological targets that maybe only used to be pursued at a drug company in the past,» says Philip Mayer, president of the American Association of Pharmaceutical Scientists in Arlington, Virginia.

There are three times more sales representatives for drugs companies in France than in Britain (although France has less than Italy, which has a similar sized population).

As the fifth birthday of his twins approaches, Greg decides to moonlight for a drugs company in order to pay -LSB-...]

He served for many years as lead national coordinating and trial counsel defending a drug company in thousands of product liability cases as well as a series of economic - loss class actions.

Mr. Simon also recently represented a generic brand drug company in an individual case alleging that the brand name manufacturer had filed false citizens petitions to delay the entry of the generic drug unto the market.

Not exact matches

Made by companies like Gilead, AbbVie, Merck, and others, drugs that treat the disease are listed at tens of thousands of dollars in the U.S..

That could help curtail a true drug crisis with devastating economic and social impacts — and which was sparked, in large part, by the actions of huge pharmaceutical companies.

In the past few years companies like Braeburn Pharmaceuticals, Intarcia Therapeutics, and Proteus Digital Health have set out to create better medical mousetraps through devices that make existing drugs more effective.

Cancer drug company Juno Therapeutics, which took in $ 145 million from Amazon's Jeff Bezos and other investors in 2014 is but one example.

WORK undertaken by researchers at the University of Western Australia has contributed to a dramatic rise in interest in a US drug company.

Instead of focusing on developing a blockbuster drug only to have it fail in trials, Tehrani's company would concentrate on the process of innovation.

So many companies have developed such increasingly effective medicines, such as those that treat more hep C strains with far shorter treatment regimens, that Gilead — a pioneer in the field with Sovaldi and Harvoni — is projecting $ 3.5 billion to $ 4 billion in U.S. sales from these kinds of drugs in 2018, a dramatic drop from nearly $ 13 billion in 2015.

Never mind that the company doesn't even have a single drug of its own in clinical trials.

May 1 - Regeneron Pharmaceuticals and Sanofi will cut the net price of their expensive cholesterol drug for Express Scripts customers in exchange for greater patient access, with some savings to be shared with consumers, the companies said on Tuesday.

Cramer was also burned on Pfizer's aborted takeover bid for drug company Allergan, which had an overseas taxation rate that would allow the company to pay lower taxes than if it were based in the U.S.

But when they broached the idea of developing such a vaccine with drug companies, nearly all of them said, «No, thank you very much, but we're not interested,» recalls Schiller in a Lasker Foundation interview.

One biotech firm, Ossianix, is already hard at work developing a VNAR - based drug - delivery system, in collaboration with the global pharmaceutical company Lundbeck, which focuses on drugs for brain disorders.

The key is to avoid a company that has only a few drugs in the pipeline that one day may or may not be approved for use by the FDA.

Sysco says he suspected the technology would need to gain FDA approval from the time the company launched in 2005, because it was designing an app that physicians would prescribe like a drug or device.

So in the case of CVS, Meyer and his team first made sure that the company's decision to rebrand was warranted: Leaders wanted to push its image as a more health - focused alternative to other drug stores.

In 2016, the company's cancer drug franchise contributed 11 percent to the company's sales.

Valeant's largest shareholder, billionaire and hedge funder John Paulson, has gained a seat on the drug maker's board, sending the beleaguered company's stock spiking more than 6 % in Monday trading (although it's still hovering at around the $ 13 mark).

Other early seeds include the hot diabetes - drug company Intarcia Therapeutics (which I wrote about in November) and the Jonathan Bush - helmed athenahealth (now worth nearly $ 5 billion), which has become a prominent force in the age of the cloud - based doctor's office and hospital.

Federal prosecutors, report the Bloomberg writers, «are also investigating relationships between PBMs and large drug companies» and the U.S. Attorney's Office in Manhattan has ordered three makers of insulin to turn over documents regarding those relationships.

In other words, how much of each company's sales are coming from drugs fresh out of the pipeline versus how much are coming from older meds?

Shares of pioneering CRISPR gene - editing firm Editas fell 7 % in early Tuesday trading after the company announced that it would delay an initial FDA filing for clinical trials of one of its lead drugs, LCA10, to the middle of next year (Editas had originally planned to file by the end of 2017).

On average, the 30 large and small pharmaceutical and biotech companies IDEA Pharma examined got just 11 % of their 2017 revenue from drugs developed within the past five years, says Mike Rea, the firm's CEO and one of the most insightful people I've met — no exaggeration — when it comes to pinpointing innovation choke points in the drug industry.

A nine - time honoree as one of the fastest - growing companies in America, SMP specializes in fertility drugs and offers a clinical patient management program.

The Food and Drug Administration delivered a boon to U.S. drug giant Johnson & Johnson on Thursday, approving the company's psoriasis treatment Tremfya (a psoriasis drug that analysts say could wring in billions of dollars in annual salDrug Administration delivered a boon to U.S. drug giant Johnson & Johnson on Thursday, approving the company's psoriasis treatment Tremfya (a psoriasis drug that analysts say could wring in billions of dollars in annual saldrug giant Johnson & Johnson on Thursday, approving the company's psoriasis treatment Tremfya (a psoriasis drug that analysts say could wring in billions of dollars in annual saldrug that analysts say could wring in billions of dollars in annual sales).

Rajiv Malik, president and executive director at EpiPen maker Mylan (essentially the company's number two exec), has been named in a wide - ranging civil suit alleging drug price collusion by numerous prominent generic drug makers.

Drug companies offer undisclosed rebates to PBMs in exchange for market share.

Cigna (ci) agreed to buy Express Scripts Holding for $ 54 billion in cash and stock, another move toward consolidation between U.S. health insurers and the companies that oversee patients» drug benefits.

Drug manufacturing and research companies are in a merger frenzy.

That provision would have allowed approved drugs that win additional FDA clearances to treat rare disorders — i.e., those that affect 200,000 or fewer Americans — extended market exclusivity in the hopes that biopharma companies would be more compelled to invest in difficult - to - treat spaces that involve costly follow - on clinical trials.

Weston said his family, who also controls Loblaw's parent company, George Weston Ltd. (TSX: WN), has undergone some major changes in the past year, including the $ 12.4 - billion blockbuster acquisition of the Shoppers Drug Mart chain.

Kite Pharma, one of the companies chasing a new generation of cancer drugs called chimeric antigen receptor T - cell (CAR - T) therapies, announced a patient death in a clinical trial of its experimental KTE - C19.

Valeant (TSX: VRX) said it had lost confidence in the Hatboro, Pa., - based company and was exploring relationships with other pharmacies to fill prescriptions for its drugs.

«Far and away the biggest value - creating step that a company can have is evolving from concept to drug,» says Brian Bapty, a biotechnology analyst with Vancouver - based brokerage Raymond James Financial Inc. «It's one of the best businesses to be in, albeit one of the higher - risk businesses.»

And within a span of six weeks this fall, Hillary Clinton caused a drop in biotech stocks with a tweet calling for greater regulation of drug prices, then single - handedly tanked stocks of private - corrections companies when she tweeted about prison reform.

These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.

Says Bapty: «If a CRO is nimble and can evolve technology that can enable its clients to get a drug approved faster or to reduce the risk of a clinical study, or even save them development money in the long run, that company will find it has a long - term business plan.»

As the largest pharmacy benefit management organization in the US, the company delivers prescription drugs programs to 83 million people.

To Wells Fargo analysts however, the bonuses seem insensitive in light of the company's recent history with drug price gouging allegations.